What is the official ID of this bill?

The official print number for this legislation is S 701.

When did the legislative process begin?

The process officially started on 2021-03-11.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/117/bills/s701/BILLS-117s701is.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Who is the primary sponsor?

The primary sponsor is Sen. Moran, Jerry [R-KS].

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Analysis and Potential Impact of S 701

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Equal Access to Allergy Testing in Medicare and Medicaid

Q: What are the main provisions?

Key points include: Standardization of coverage for allergy tests (blood tests and skin prick tests) under Medicare and Medicaid. Increased access to allergy diagnostics for individuals using these insurance programs. Potential reduction in treatment costs and improved health outcomes through early and accurate allergy diagnosis. Changes take effect from January 1, 2022.

New rules ensure that two main types of allergy tests – blood tests and skin prick tests – will be covered equally under Medicare and Medicaid programs. This means citizens covered by these programs will have easier and equal access to allergy diagnostics, potentially improving treatment and reducing healthcare costs.

Key points

Standardization of coverage for allergy tests (blood tests and skin prick tests) under Medicare and Medicaid.

Increased access to allergy diagnostics for individuals using these insurance programs.

Potential reduction in treatment costs and improved health outcomes through early and accurate allergy diagnosis.

Changes take effect from January 1, 2022.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Allergy Testing Access Act of 2021

Print number: S 701

Sponsor: Sen. Moran, Jerry [R-KS]

Process start date: 2021-03-11

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Equal Access to Allergy Testing in Medicare and Medicaid

Key Questions about Equal Access to Allergy Testing in Medicare and Medicaid